For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Cardurion Pharmaceuticals, LLC

USPTO Granted Patents = 10

EPO Patents = 1

Trademarks = 4

Forward Citations = 9

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

62 inventors (with patents filed for the assignee):

Tomohiro Okawa (4 out of 17 patents)

Nobuyuki Matsunaga (4 out of 9 patents)

Takashi Nakahata (4 out of 4 patents)

4. Yasufumi Miyamoto (4 out of 13 patents)

5. Junya Shirai (4 out of 26 patents)

6. Zenyu Shiokawa (4 out of 11 patents)

7. Akito Shibuya (4 out of 12 patents)

8. Rei Okamoto (2 out of 11 patents)

9. Hiroki Takahagi (2 out of 3 patents)

10. Yuta Tanaka (2 out of 10 patents)

11. Takeshi Yoshikawa (2 out of 5 patents)

12. Yoshito Terao (2 out of 9 patents)

13. Takafumi Yukawa (2 out of 8 patents)

14. Keiko Kakegawa (2 out of 16 patents)

15. Yoichi Nishikawa (2 out of 10 patents)

10 patents: Sort by Forward Citations

1. 12466832 - Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one (2025-11-11),

2. 12213975 - PDE9 inhibitors for treating sickle cell disease (2025-02-04),

3. 12006319 - Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one (2024-06-11),

4. 11999741 - Process for the synthesis of 6-((3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-3-(tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one (2024-06-04),

5. 11795172 - Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as CaMKII inhibitors (2023-10-24),

6. 11197858 - Substituted amines for treating cardiac diseases (2021-12-14),

7. 11130752 - Aminopyrimidine compound (2021-09-28),

8. 10870656 - Methods for treatment of heart failure (2020-12-22),

9. 10822346 - Meglumine salts of thienopyrimidines (2020-11-03),

10. 10543212 - Substituted amines for treating cardiac diseases (2020-01-28),

Cardurion Pharmaceuticals, LLC is a biopharmaceutical company dedicated to developing novel therapies for cardiovascular diseases. With a focus on improving patient outcomes and quality of life, Cardurion is committed to advancing innovative treatments through research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

10 Patents

#203 in Cambridge, MA

#1,719 in Massachusetts

#28,930 in US

#54,212 in the World

Cambridge, MA, United States of America

Cardurion Pharmaceuticals, LLC

Forward Citations = 9

62 inventors:

Tomohiro Okawa (4 out of 17 patents)

Nobuyuki Matsunaga (4 out of 9 patents)

Takashi Nakahata (4 out of 4 patents)

4. Yasufumi Miyamoto (4 out of 13 patents)

5. Junya Shirai (4 out of 26 patents)

Please report any incorrect information to support@idiyas.com

Loading…